Targeting RTN4/NoGo-Receptor reduces levels of ALS protein ataxin-2
Authors:
Open Access
- 25 October 2022
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 41 (4) , 111505
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- NIA (R01AG064690)
- Maze Therapeutics (63/388,086, AXER-204)
- NINDS (R35NS097263)
- Stanford University
- Takeda Science Foundation
- Robert Packard Center for ALS Research, Johns Hopkins University
- National Institutes of Health (F31NS125681, F32NS116208, R35NS097283, T32AG047126, T32NS007280)
- Wu Tsai Neurosciences Institute, Stanford University
This publication has 59 references indexed in Scilit:
- Local RNA Translation at the Synapse and in Disease: Figure 1.The Journal of Neuroscience, 2011
- Cartilage Acidic Protein–1B (LOTUS), an Endogenous Nogo Receptor Antagonist for Axon Tract FormationScience, 2011
- Recovery from chronic spinal cord contusion after nogo receptor interventionAnnals of Neurology, 2011
- Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALSNature, 2010
- TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegenerationHuman Molecular Genetics, 2010
- Reticulon-4A (Nogo-A) Redistributes Protein Disulfide Isomerase to Protect Mice from SOD1-Dependent Amyotrophic Lateral SclerosisJournal of Neuroscience, 2009
- Neuronal Nogo-A Modulates Growth Cone Motility via Rho-GTP/LIMK1/Cofilin in the Unlesioned Adult Nervous SystemJournal of Biological Chemistry, 2009
- The Nogo-66 Receptor NgR1 Is Required Only for the Acute Growth Cone-Collapsing But Not the Chronic Growth-Inhibitory Actions of Myelin InhibitorsJournal of Neuroscience, 2007
- Ataxin-2 Interacts with the DEAD/H-Box RNA Helicase DDX6 and Interferes with P-Bodies and Stress GranulesMolecular Biology of the Cell, 2007
- The neurite outgrowth inhibitor Nogo‐A promotes denervation in an amyotrophic lateral sclerosis modelEMBO Reports, 2006